Philadelphia Endocrine Society
Philadelphia Endocrine Society shows strong financial health and program spending efficiency with zero officer compensation.
EIN: 200106268 · Camden, NJ · NTEE: E70 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $238K |
| Total Expenses | $103K |
| Program Spending | 90% |
| CEO/Top Officer Pay | $586,276. |
| Net Assets | $586K |
| Transparency Score | 92/100 |
Is Philadelphia Endocrine Society Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Philadelphia Endocrine Society directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Philadelphia Endocrine Society
Philadelphia Endocrine Society (EIN: 200106268) is a nonprofit organization based in Camden, NJ, classified under NTEE code E70. The organization reported total revenue of $238K and total assets of $654K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Philadelphia Endocrine Society's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Philadelphia Endocrine Society is a small nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 10.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $174K |
| Total Expenses | $103K |
| Surplus / Deficit | +$71K |
| Total Assets | $586K |
| Net Assets | $586K |
| Operating Margin | 40.6% |
| Months of Reserves | 68.2 months |
Financial Health Grade: A
In 2023, Philadelphia Endocrine Society reported a surplus of $71K with revenue exceeding expenses, holds 68.2 months of operating reserves (strong position).
Financial Trends
Over 13 years of filings (2011–2023), Philadelphia Endocrine Society's revenue has grown at a compound annual growth rate (CAGR) of 10.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +70.5% | +25.4% | +13.7% |
| 2022 | +75.8% | +93.4% | +4.0% |
| 2021 | -15.1% | -4.5% | +3.2% |
| 2020 | -47.1% | -48.4% | +5.2% |
| 2019 | -10.8% | +19.8% | +10.3% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Philadelphia Endocrine Society with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Philadelphia Endocrine Society allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $71K, with revenue exceeding expenses.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that the organization's leadership is entirely volunteer-based, which is highly commendable for a society of its size with assets of $586,276.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Philadelphia Endocrine Society:
- Strong program spending ratio (90% in 2023)
- Consistent asset growth over the past decade (from $127,902 in 2014 to $586,276 in 2023)
- Zero reported officer compensation, indicating volunteer leadership
- No reported liabilities across all filings, showing strong financial stability
- Excellent transparency with 13 years of consistent IRS 990 filings
Frequently Asked Questions about Philadelphia Endocrine Society
Is Philadelphia Endocrine Society a legitimate charity?
Philadelphia Endocrine Society (EIN: 200106268) is a registered tax-exempt nonprofit based in New Jersey. Our AI analysis gives it a Mission Score of 92/100. It has 13 years of IRS 990 filings on record. Total revenue: $238K. No red flags identified. 5 strengths noted. Financial health grade: A.
How does Philadelphia Endocrine Society spend its money?
Philadelphia Endocrine Society directs 90% of its spending to programs and services. Fundraising costs 3%. This exceeds the 65% industry benchmark.
Are donations to Philadelphia Endocrine Society tax-deductible?
Philadelphia Endocrine Society is registered as a tax-exempt nonprofit (EIN: 200106268). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Philadelphia Endocrine Society CEO make?
Philadelphia Endocrine Society's highest-compensated officer earns $586,276. annually. The organization reported $238K in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Philadelphia Endocrine Society's spending goes to programs?
Philadelphia Endocrine Society directs 90% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Philadelphia Endocrine Society compare to similar nonprofits?
With a transparency score of 92/100 (Excellent), Philadelphia Endocrine Society is above average for NTEE category E70 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Philadelphia Endocrine Society located?
Philadelphia Endocrine Society is headquartered in Camden, New Jersey and files with the IRS under EIN 200106268. It is classified under NTEE code E70.
How many years of IRS 990 filings does Philadelphia Endocrine Society have?
Philadelphia Endocrine Society has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $238K in total revenue.
Is Philadelphia Endocrine Society a good charity?
Based on its financial data, the Philadelphia Endocrine Society appears to be a very good charity. It demonstrates strong program spending (90% in 2023), consistent asset growth, and excellent transparency with 13 years of filings and no reported officer compensation.
How has the organization's financial health changed over time?
The organization's financial health has significantly improved over time, with assets growing from $127,902 in 2014 to $586,276 in 2023, and revenue showing a positive trend, indicating sustainable growth and stability.
What is the organization's approach to executive compensation?
The organization's approach to executive compensation is to have none; all officer compensation is reported as 0% across all available filings, indicating a volunteer-led structure.
Filing History
IRS 990 filing history for Philadelphia Endocrine Society showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Philadelphia Endocrine Society's revenue has grown by 239.8%, moving from $51K to $174K. Total assets increased by 1880.9% over the same period, from $30K to $586K. Total functional expenses rose by 150.2%, from $41K to $103K. In its most recent filing year (2023), Philadelphia Endocrine Society reported a surplus of $71K, with revenue exceeding expenses.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $174K | $103K | $586K | $0 | — | View 990 |
| 2022 | $102K | $82K | $516K | $0 | — | View 990 |
| 2021 | $58K | $43K | $496K | $0 | — | View 990 |
| 2020 | $68K | $45K | $481K | $0 | — | — |
| 2019 | $129K | $86K | $457K | $0 | — | View 990 |
| 2018 | $145K | $72K | $414K | $0 | — | View 990 |
| 2017 | $158K | $72K | $342K | $0 | — | View 990 |
| 2016 | $135K | $78K | $255K | $0 | — | View 990 |
| 2015 | $126K | $56K | $198K | $0 | — | View 990 |
| 2014 | $93K | $53K | $128K | $0 | — | View 990 |
| 2013 | $59K | $44K | $88K | $0 | — | View 990 |
| 2012 | $86K | $43K | $73K | $0 | — | View 990 |
| 2011 | $51K | $41K | $30K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $174K, expenses of $103K, and assets of $586K (revenue +70.5% year-over-year).
- 2022: Revenue of $102K, expenses of $82K, and assets of $516K (revenue +75.8% year-over-year).
- 2021: Revenue of $58K, expenses of $43K, and assets of $496K (revenue -15.1% year-over-year).
- 2020: Revenue of $68K, expenses of $45K, and assets of $481K (revenue -47.1% year-over-year).
- 2019: Revenue of $129K, expenses of $86K, and assets of $457K (revenue -10.8% year-over-year).
- 2018: Revenue of $145K, expenses of $72K, and assets of $414K (revenue -8.6% year-over-year).
- 2017: Revenue of $158K, expenses of $72K, and assets of $342K (revenue +16.9% year-over-year).
- 2016: Revenue of $135K, expenses of $78K, and assets of $255K (revenue +7.7% year-over-year).
- 2015: Revenue of $126K, expenses of $56K, and assets of $198K (revenue +35.7% year-over-year).
- 2014: Revenue of $93K, expenses of $53K, and assets of $128K (revenue +55.9% year-over-year).
- 2013: Revenue of $59K, expenses of $44K, and assets of $88K (revenue -30.8% year-over-year).
- 2012: Revenue of $86K, expenses of $43K, and assets of $73K (revenue +68.2% year-over-year).
- 2011: Revenue of $51K, expenses of $41K, and assets of $30K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Philadelphia Endocrine Society:
Data Sources and Methodology
This transparency report for Philadelphia Endocrine Society is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.